Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04608552 · ClinicalTrials.gov registry record · NA

Effect of Myofunctional Therapy on OSA

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
209
Enrollment target

NCT04608552: Completed NA study, sponsored by VA Office of Research and Development.

NCT04608552 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 209 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04608552, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
209 participants
Enrollment target

Study Summary

The primary medical therapies for patients with Obstructive Sleep Apnea syndrome (OSA) require the use of medical devices on a nightly basis to help control breathing during sleep, which can be difficult for patients with mild-to-moderate disease. Because many patients use these therapies on a limited basis, or stop using them altogether, they continue to be at increased risk of the consequences of untreated OSA. Untreated and undertreated OSA compounds the risk of OSA consequences over time, particularly with increasing age and weight. Orofacial Myofunctional Therapy (OMT) takes a rehabilitative approach to OSA and is comprised of isotonic and isometric exercises that target the oral (e.g., tongue) and oropharyngeal (e.g., soft palate, lateral pharyngeal wall) to help restore normal breathing and airway patency at night while asleep. Should the study have positive findings, OMT could become an important alternative therapy for patients with mild-to-moderate disease because patients could utilize a therapy that improves their nighttime breathing through daytime exercises and without the need for a burdensome medical device.

Interventions

  • BEHAVIORAL OMT Exercises
  • BEHAVIORAL Nasal Breathing Exercises
  • OTHER Use of Nasal Lavage

Trial Details

FieldValue
Enrollment Target 209 participants
Start Date 2021-08-02
Est. Completion 2025-12-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT04608552

The ClinicalTrials.gov registry entry for NCT04608552 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which OMT Exercises is the first listed.

NCT04608552 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04608552 about?

NCT04608552 is a clinical study titled "Effect of Myofunctional Therapy on OSA". The primary medical therapies for patients with Obstructive Sleep Apnea syndrome (OSA) require the use of medical devices on a nightly basis to help control breathing during sleep, which can be difficult for patients with mild-to-moderate disease. Because many patients use these therapies on a limit...

What is the current status of trial NCT04608552?

This trial is currently completed. It is a NA study. The enrollment target is 209 participants. The study started on 2021-08-02. Estimated completion is 2025-12-31.

What interventions are being tested in trial NCT04608552?

The interventions under investigation include: OMT Exercises (BEHAVIORAL), Nasal Breathing Exercises (BEHAVIORAL), Use of Nasal Lavage (OTHER).

Who is sponsoring clinical trial NCT04608552?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.